Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-05-01

FDA Approved: ELELYSO — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved ELELYSO (taliglucerase alfa) from Pfizer as the original application for Gaucher disease. This approval introduced the first plant-cell–expressed e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ELELYSO (TALIGLUCERASE ALFA)

Snippet

ORIG AP for ELELYSO (TALIGLUCERASE ALFA)